FAKTOR-OPTIONSSCHEIN - BIOGEN IDEC | Delayed Deutsche Boerse AG 02:07:33 2024-05-09 am EDT | ||
| 5.11 EUR | +0.20% |
|
| Current month | -3.59% | ||
| 1 month | -6.42% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-09 | 5.11 | +0.20% | 0 |
| 24-05-08 | 5.1 | -1.16% | 0 |
| 24-05-07 | 5.16 | +1.38% | 0 |
| 24-05-06 | 5.09 | -1.55% | 0 |
| 24-05-03 | 5.17 | -2.27% | 0 |
Delayed Quote Deutsche Boerse AG
Last update May 09, 2024 at 02:07 am EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SB0Q0K |
| ISIN | DE000SB0Q0K5 |
| Date issued | 2020-06-04 |
| Strike | 302.6 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 8.97 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.29 € |
|---|---|
| Lowest since issue | 3.15 € |
| Spread | 0.06 € |
| Spread % | 1.16% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
219.7
USD
Average target price
285.9
USD
Spread / Average Target
+30.13%
- Stock Market
- Certificates
- Certificat